Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients who are 18 or older

• Diagnosis of Idiopathic Pulmonary Fibrosis

• Treated at the Simmons Center

Locations
United States
Pennsylvania
Michelle F MacPherson
RECRUITING
Pittsburgh
Contact Information
Primary
Michelle MacPherson, MAT
macphersonmj@upmc.edu
412-647-4537
Backup
Michelle Meyers, BSN RN
meyersma@upmc.edu
412-692-2149
Time Frame
Start Date: 2005-10
Estimated Completion Date: 2030-07
Participants
Target number of participants: 500
Authors
Sponsors
Leads: University of Pittsburgh

This content was sourced from clinicaltrials.gov